Barclays
TNYA icon

Barclays’s Tenaya Therapeutics TNYA Stock Holding History

Barclays’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.46K Sell
10,777
-174,224
-94% -$129K ﹤0.01% 4736
2025
Q4 		$132K Buy
185,001
+185,000
+18,500,000% +$252K ﹤0.01% 4496
2025
Q3 		$2 Sell
1
-9,536
-100% -$9.61K ﹤0.01% 5445
2025
Q2 		$5.83K Sell
9,537
-50,135
-84% -$25.5K ﹤0.01% 4958
2025
Q1 		$34K Sell
59,672
-24,955
-29% -$24.6K ﹤0.01% 4694
2024
Q4 		$121K Sell
84,627
-184,837
-69% -$414K ﹤0.01% 4546
2024
Q3 		$520K Sell
269,464
-4,022
-1% -$11.4K ﹤0.01% 3751
2024
Q2 		$848K Sell
273,486
-527
-0.2% -$2.18K ﹤0.01% 2699
2024
Q1 		$1.43M Buy
274,013
+207,618
+313% +$993K ﹤0.01% 2841
2023
Q4 		$215K Sell
66,395
-183,163
-73% -$395K ﹤0.01% 4384
2023
Q3 		$636K Buy
249,558
+240,436
+2,636% +$1.01M ﹤0.01% 2643
2023
Q2 		$53.5K Sell
9,122
-20,877
-70% -$121K ﹤0.01% 3812
2023
Q1 		$85.5K Buy
29,999
+14,720
+96% +$41.4K ﹤0.01% 4262
2022
Q4 		$30.7K Buy
15,279
+6,319
+71% +$15.4K ﹤0.01% 4714
2022
Q3 		$26K Buy
8,960
+7,558
+539% +$35.3K ﹤0.01% 3984
2022
Q2 		$8K Sell
1,402
-3,240
-70% -$26.2K ﹤0.01% 4702
2022
Q1 		$55K Buy
+4,642
New +$56.2K ﹤0.01% 4082

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's TNYA Position: Q1 2026 in Review

Barclays reduced its Tenaya Therapeutics (TNYA) stake by 94% in Q1 2026, selling an estimated $129K and leaving 10,777 shares worth $7.46K. The position accounts for ﹤0.01% of the portfolio, ranked #4736.

Barclays first reported a position in TNYA in Q1 2022 and has held it in 17 quarters since. The position peaked at $1.43M in Q1 2024. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Barclays held 10,777 shares of Tenaya Therapeutics worth $7.46K as of Q1 2026.
  • Barclays sold 174,224 Tenaya Therapeutics shares in Q1 2026, an estimated $129K.
  • Tenaya Therapeutics made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4736 holding.
  • Barclays first reported a position in Tenaya Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Tenaya Therapeutics position peaked at $1.43M in Q1 2024.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.